GSK Handed $106M Verdict For Paxil Generic Contract Breach

GSK Handed $106M Verdict For Paxil Generic Contract Breach

A New Jersey federal jury on Tuesday slapped GlaxoSmithKline LLC with a $106.7 million verdict for allegedly breaching an exclusive contract with Mylan Inc. by allowing Apotex Inc. to sell generic versions of its antidepressant Paxil as part of an antitrust ...read more

  • Tags: